SPIB ETF Analysis: Barclays Intermediate Term | NYSE
US Corporate Bonds | NYSE, USA | Market Cap: 11.404m USD | 12M Return: 0.9% | US78464A3757 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 218M
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
SPIB is a U.S.-listed corporate bond ETF issued by State Street Global Advisors under its SPDR brand. The fund pursues a passive, index-replicating strategy, investing at least 80% of its total assets in securities that make up the underlying Barclays index and in holdings deemed to have substantially identical economic characteristics. The index it tracks focuses on the performance of U.S. corporate bonds with maturities between 1 and 10 years, placing SPIB squarely in the intermediate-term slice of the investment-grade corporate debt market. This maturity range typically offers investors a balance between yield and interest-rate sensitivity, sitting between short-term and long-term fixed income.
Launched in February 2009 and categorized as a Corporate Bond ETF, SPIB is one of the larger funds in its segment by assets. As an ETF structure, it trades on an exchange like a stock while holding a diversified basket of individual corporate bonds, giving investors intraday liquidity and transparent pricing that traditional mutual funds cannot offer. Its focus on U.S. dollar-denominated corporate debt also means credit risk and corporate earnings health are key underlying drivers of fund performance.
- Fed rate cuts lift intermediate corporate bond prices
- Widening credit spreads pressure SPIB NAV on recession risk
- Strong ETF inflows boost assets under management
- Rising Treasury yields weigh on bond fund returns
As of November 03, 2026, the stock is trading at USD 32.53 with a total of 7,195,859 shares traded. Over the past week, the price has changed by +0.37%, over one month by +1.50%, over three months by -0.42% and over the past year by +0.90%.
Current recommended Stop Loss: 32.30 (which is 0.7% or 2.1 ATR below the current price).
Barclays Intermediate Term has no consensus analysts rating.